Filing metadata

Accession number
0001169245-21-000103
Form type
Form 4
Filer
PhaseBio Pharmaceuticals Inc
CIK
CIK 1169245
Filed
Nov 03, 2021
Reporting period
Nov 03, 2021
Description
Insider transaction

Explore SEC Filings Hub